Axsome Therapeutics (AXSM) Amortizatization of Intangibles (2015 - 2026)
Axsome Therapeutics recorded quarterly Amortizatization of Intangibles of $1.6 million in Q1 2026, up 576.36% quarter-over-quarter from -$330000.0 in Q4 2025, and up 135.68% year-over-year from $667000.0 in Q1 2025.
Axsome Therapeutics' Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 135.68% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $2.5 million (down 70.08% YoY), while the FY2025 annual figure was $1.3 million, down 79.62% from the prior year.
- Amortizatization of Intangibles came in at $1.6 million for Q1 2026 at Axsome Therapeutics, up from -$330000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5.7 million in Q4 2024 to a low of -$330000.0 in Q4 2025.
- A 5-year average of $1.3 million and a median of $1.6 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 1154.41% in 2024 and slumped 105.79% in 2025, its largest moves.
- Axsome Therapeutics' Amortizatization of Intangibles stood at $1.6 million in 2022, then plunged by 71.75% to $454000.0 in 2023, then jumped by 1154.41% to $5.7 million in 2024, then tumbled by 105.79% to -$330000.0 in 2025, then soared by 576.36% to $1.6 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1.6 million, -$330000.0, and $684000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | -330,000.00 |
| Dec 31, 2025 | -330,000.00 |
| Sep 30, 2025 | 684,000.00 |
| Sep 30, 2025 | 684,000.00 |
| Jun 30, 2025 | 537,000.00 |
| Jun 30, 2025 | 537,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Dec 31, 2024 | 5.70 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 263,000.00 |
| Jun 30, 2024 | 263,000.00 |
| Mar 31, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 454,000.00 |
| Dec 31, 2023 | 454,000.00 |
| Sep 30, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 926,000.00 |
| Jun 30, 2022 | 926,000.00 |
| Mar 31, 2022 | 275,000.00 |
| Mar 31, 2022 | 275,000.00 |
| Dec 31, 2021 | 274,051.00 |
| Dec 31, 2021 | 274,051.00 |
| Sep 30, 2021 | 135,885.00 |
| Sep 30, 2021 | 135,885.00 |
| Jun 30, 2021 | 132,508.00 |
| Jun 30, 2021 | 132,508.00 |
| Mar 31, 2021 | 262,764.00 |
| Mar 31, 2021 | 262,764.00 |
| Dec 31, 2020 | -437,155.00 |
| Dec 31, 2020 | -437,155.00 |
| Sep 30, 2020 | 46,920.00 |
| Sep 30, 2020 | 46,920.00 |
| Jun 30, 2020 | 59,998.00 |
| Jun 30, 2020 | 59,998.00 |
| Mar 31, 2020 | 177,652.00 |
| Mar 31, 2020 | 177,652.00 |
| Dec 31, 2019 | 178,251.00 |
| Dec 31, 2019 | 178,251.00 |
| Sep 30, 2019 | 56,602.00 |
| Sep 30, 2019 | 56,602.00 |
| Jun 30, 2019 | 61,126.00 |
| Jun 30, 2019 | 61,126.00 |
| Mar 31, 2019 | 107,433.00 |
| Mar 31, 2019 | 107,433.00 |
| Dec 31, 2018 | 82,055.00 |
| Dec 31, 2018 | 82,055.00 |
| Sep 30, 2018 | 24,940.00 |
| Sep 30, 2018 | 24,940.00 |
| Jun 30, 2018 | 26,346.00 |
| Jun 30, 2018 | 26,346.00 |
| Mar 31, 2018 | 108,481.00 |
| Mar 31, 2018 | 108,481.00 |
| Dec 31, 2017 | 117,647.00 |
| Dec 31, 2017 | 117,647.00 |
| Sep 30, 2017 | 31,549.00 |
| Sep 30, 2017 | 31,549.00 |
| Jun 30, 2017 | 30,489.00 |
| Jun 30, 2017 | 30,489.00 |
| Mar 31, 2017 | 115,645.00 |
| Mar 31, 2017 | 115,645.00 |
| Dec 31, 2015 | -31,763.00 |
| Dec 31, 2015 | -31,763.00 |
| Sep 30, 2015 | 22,052.00 |
| Sep 30, 2015 | 22,052.00 |
| Jun 30, 2015 | 35,847.00 |
| Jun 30, 2015 | 35,847.00 |
| Mar 31, 2015 | 16,066.00 |
| Mar 31, 2015 | 16,066.00 |